Nutrition in brain development and aging: Role of essential fatty acids

Nutrition Reviews

Volumn 64, Issue 5 SUPPL. 1, 2006, Pages

  Uauy, Ricardo ^a,b   Dangour, Alan D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Aging; Brain development; Essential fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; LINOLEIC ACID; POLYUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

AGING; ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BREAST FEEDING; CELL DIFFERENTIATION; CHILD GROWTH; COGNITION; DEMENTIA; DIET; DIET SUPPLEMENTATION; HUMAN; MENTAL HEALTH; NUTRITION; PERIPHERAL NEUROPATHY; PSYCHOMOTOR DEVELOPMENT; RETINA DEVELOPMENT; REVIEW; RISK ASSESSMENT; VISUAL DISORDER; ANIMAL; ARTIFICIAL MILK; BRAIN; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; PRENATAL DEVELOPMENT; RETINA;

AGING; ANIMALS; BRAIN; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-3; HUMANS; INFANT FORMULA; NUTRITION PHYSIOLOGY; RETINA;

EID: 33745498488     PISSN: 00296643     EISSN: 00296643     Source Type: Journal    
DOI: 10.1301/nr.2006.may.S24-S33     Document Type: Review

References (91)

1. Dobbing J, Hopewell JW, Lynch A. Vulnerability of developing brain. VII. Permanent deficit of neurons in cerebral and cerebellar cortex following early mild undernutrition. Exp Neurol. 1971;32:439-447.
2. Levitsky DA, Strupp BJ. Malnutrition and the brain: changing concepts, changing concerns. J Nutr. 1995;125(8 suppl):2212S-2220S.
3. Burr GO, Burr MM. Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr Rev. 1973;31:248-249.
4. Hansen AE, Wiese HF, Boelsche AE, Haggard ME, Adam DJD, Davis H. Role of linoleic acid in infant nutrition: clinical and chemical study of 428 infants fed on milk mixtures varying in kind and amount of fat. Pediatrics. 1963;31:171-192.
5. Holman RT, Johnson SB, Hatch TF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr. 1982;35:617-623.
6. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54:438-463.
7. Anderson RE, Benolken RM, Dudley PA, Landis DJ, Wheeler TG. Proceedings: Polyunsaturated fatty acids of photoreceptor membranes. Exp Eye Res. 1974;18:205-213.
8. Ballabriga A. Essential fatty acids and human tissue composition. An overview. Acta Paediatr Suppl. 1994;402:63-68.
9. Byard RW, Makrides M, Need M, Neumann MA, Gibson RA. Sudden infant death syndrome: effect of breast and formula feeding on frontal cortex and brainstem lipid composition. J Paediatr Child Health. 1995;31:14-16.
10. Galli C, Trzeciak HI, Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta. 1971;248:449-454.
11. Greiner RC, Winter J, Nathanielsz PW, Brenna JT. Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary alpha-linolenic and docosahexaenoic acids. Pediatr Res. 1997;42:826-834.
12. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet. 1992;340(8823):810 - 813.
13. Galli C, Simopoulos AP, Tremoli EE. Effects of fatty acids and lipids in health and disease. World Rev Nutr Diet. 1994;76:1-149.
14. Hohl CM, Rosen P. The role of arachidonic acid in rat heart cell metabolism. Biochim Biophys Acta. 1987;921:356-363.
15. Mitchell DC, Niu SL, Litman BJ. DHA-rich phospholipids optimize G-protein-coupled signaling. J Pediatr. 2003;143(4 suppl):S80-S86.
16. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta. 1984;779:89-137.
17. Salem N Jr, Shingu T, Kim HY, Hullin F, Bougnoux P, Karanian JW. Specialisation in membrane structure and metabolism with respect to polyunsaturated lipids. In: Karnovsky ML, Leaf A, Bollis LC, eds. Biological Membranes: Aberrations in Membrane Structure and Function. New York: Alan R. Liss; 1988; 319-333.
18. Foot M, Cruz TF, Clandinin MT. Effect of dietary lipid on synaptosomal acetylcholinesterase activity. Biochem J. 1983;211:507-509.
19. Wheeler TG, Benolken RM, Anderson RE. Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science. 1975;188(4195):1312-1314.
20. Lands WE. Renewed questions about polyunsaturated fatty acids. Nutr Rev. 1986;44:189-195.
21. Murphy MG. Dietary fatty acids and membrane protein function. J Nutr Biochem. 1990;1:68-79.
22. Wood JN. Essential fatty acids and their metabolites in signal transduction. Biochem Soc Trans. 1990;18:785-786.
23. Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys. 1992;294:564-570.
24. Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J Biol Chem. 1992;267:5937-5941.
25. Evers AS, Elliott WJ, Lefkowith JB, Needleman P. Manipulation of rat brain fatty acid composition alters volatile anesthetic potency. J Clin Invest. 1986;77:1028-1033.
26. Love JA, Saum WR, McGee R Jr. The effects of exposure to exogenous fatty acids and membrane fatty acid modification on the electrical properties of NG108-15 cells. Cell Mol Neurobiol. 1985;5:333-352.
27. Kim HY, Edsall L, Ma YC. Specificity of polyunsaturated fatty acid release from rat brain synaptosomes. Lipids. 1996;(31 suppl):S229-S233.
28. Xu LZ, Sanchez R, Sali A, Heintz N. Ligand specificity of brain lipid-binding protein. J Biol Chem. 1996;271:24711-24719.
29. Rotstein NP, Politi LE, Aveldano MI. Docosahexaenoic acid promotes differentiation of developing photoreceptors in culture. Invest Ophthalmol Vis Sci. 1998;39:2750-2758.
30. Rojas CV, Martinez JI, Flores I, Hoffman DR, Uauy R. Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2003;44:3170-3177.
31. Aamodt SM, Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv Neurol. 1999;79:133-144.
32. Redburn-Johnson D. GABA as a developmental neurotransmitter in the outer plexiform layer of the vertebrate retina. Perspect Dev Neurobiol. 1998;5:261-267.
33. Mitchell CK, Huang B, Redburn-Johnson DA. GABA(A) receptor immunoreactivity is transiently expressed in the developing outer retina. Vis Neurosci. 1999;16:1083-1088.
34. Ongari MA, Ritter JM, Orchard MA, Waddell KA, Blair IA, Lewis PJ. Correlation of prostacyclin synthesis by human umbilical artery with status of essential fatty acid. Am J Obstet Gynecol. 1984;149:455-460.
35. Honstra G, Al MD, van Houwelingen AC. Essential fatty acids, pregnancy and pregnancy outcome. In: Bindels JC, Goededhart AC, Visser HKA, eds. Recent Developments in Infant Nutrition. Dordrecht, Netherlands: Kluwer Academic Publishers; 1996;51-63.
36. van Houwelingen AC, Foreman-van Drongelen MM, Nicolini U, et al. Essential fatty acid status of fetal plasma phospholipids: similar to postnatal values obtained at comparable gestational ages. Early Hum Dev. 1996;46:141-152.
37. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev. 1980;4:121-129.
38. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev. 2004(1):CD000375.
39. O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics. 2001;108:359-371.
40. Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146:461-468.
41. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet. 1998;352(9129):688-691.
42. Makrides M, Neumann MA, Jeffrey B, Lien EL, Gibson RA. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth. Am J Clin Nutr. 2000;71:120-129.
43. Birch E, Birch D, Hoffman D, Hale L, Everett M, Uauy R. Breast-feeding and optimal visual development. J Pediatr Ophthalmol Strabismus. 1993;30:33-38.
44. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.
45. Auestad N, Montalto MB, Hall RT, et al. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross Pediatric Lipid Study. Pediatr Res. 1997;41:1-10.
46. Carnielli VP, Rossi K, Badon T, et al. Medium-chain triacylglycerols in formulas for preterm infants: effect on plasma lipids, circulating concentrations of medium-chain fatty acids, and essential fatty acids. Am J Clin Nutr. 1996;64:152-158.
47. Innis SM, Nelson CM, Rioux MF, King DJ. Development of visual acuity in relation to plasma and erythrocyte omega-6 and omega-3 fatty acids in healthy term gestation infants. Am J Clin Nutr. 1994;60:347-352.
48. Innis SM, Nelson CM, Lwanga D, Rioux FM, Waslen P. Feeding formula without arachidonic acid and docosahexaenoic acid has no effect on preferential looking acuity or recognition memory in healthy full-term infants at 9 mo of age. Am J Clin Nutr. 1996;64:40-46.
49. Innis SM, Akrabawi SS, Diersen-Schade DA, Dobson MV, Guy DG. Visual acuity and blood lipids in term infants fed human milk or formulae. Lipids. 1997;32:63-72.
50. Carlson SE, Ford AJ, Werkman SH, Peeples JM, Koo WW. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res. 1996;39:882-888.
51. Jorgensen MH, Hernell O, Lund P, Holmer G, Michaelsen KF. Visual acuity and erythrocyte docosahexaenoic acid status in breast-fed and formulafed term infants during the first four months of life. Lipids. 1996;31:99-105.
52. Agostoni C, Trojan S, Bellu R, Riva E, Giovannini M. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res. 1995;38:262-266.
53. Agostoni C, Trojan S, Bellu R, Riva E, Bruzzese MG, Giovannini M. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch Dis Child. 1997;76:421-424.
54. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr. 1997;51:578-584.
55. Forsyth JS, Willatts P, DiModogno MK, Varma S, Colvin M. Do long-chain polyunsaturated fatty acids influence infant cognitive behaviour? Biochem Soc Trans. 1998;26:252-257.
56. Slater A. Individual differences in infancy and later IQ. J Child Psychol Psychiatry. 1995;36:69-112.
57. Courage ML, McCloy UR, Herzberg GR, et al. Visual acuity development and fatty acid composition of erythrocytes in full-term infants fed breast milk, commercial formula, or evaporated milk. J Dev Behav Pediatr. 1998;19:9-17.
58. Makrides M, Simmer K, Goggin M, Gibson RA. Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. Pediatr Res. 1993;33(4 part 1):425-427.
59. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary omega 3-fatty acid intake. Am J Clin Nutr. 1993;57(5 suppl):801S-806S.
60. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209.
61. Birch EE, Castaneda YS, Wheaton DH, Birch DG, Uauy RD, Hoffman DR. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871-879.
62. Lucas A, Stafford M, Morley R, et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial. Lancet. 1999;354(9194):1948-1954.
63. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics. 2003;111:e39-e44.
64. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40:1-94.
65. Aoki C, Siekevitz P. Ontogenetic changes in the cyclic adenosine 3′-,5′-monophosphate-stimulatable phosphorylation of cat visual cortex proteins, particularly of microtubule-associated protein 2 (MAP 2): effects of normal and dark rearing and of the exposure to light. J Neurosci. 1985;5:2465-2483.
66. Hubel DH, Wiesel TN. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol. 1970;206:419-436.
67. Suzuki H, Hayakawa S, Wada S. Effect of age on the modification of brain polyunsaturated fatty acids and enzyme activities by fish oil diet in rats. Mech Aging Dev. 1989;50:17-25.
68. Favrelere S, Stadelmann-Ingrand S, Huguet F, et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging. 2000;21:653-660.
69. Soderberg M, Edlund C, Kristensson K, Dallner G. Lipid compositions of different regions of the human brain during aging. J Neurochem. 1990;54:415-423.
70. Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids. 1991;26:421-425.
71. Suzuki H, Park SJ, Tamura M, Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Aging Dev. 1998;101:119-128.
72. Lim SY, Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice. J Nutr. 2000;130:1629-1632.
73. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem N Jr. Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci. 2002;116:1022-1031.
74. Biagi PL, Bordoni A, Hrelia S, Celadon M, Horrobin DF. Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta. 1991;1083:187-192.
75. Horrobin DF. Loss of delta-6-desaturase activity as a key factor in aging. Med Hypotheses. 1981;7:1211-1220.
76. Bourre JM, Piciotti M, Dumont O. Delta 6 desaturase in brain and liver during development and aging. Lipids. 1990;25:354-356.
77. Cook HW. Brain metabolism of alpha-linolenic acid during development. Nutrition. 1991;7:440-442.
78. Murray CA, Lynch MA. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J Biol Chem. 1998;273:12161-12168.
79. Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004;62:275-280.
80. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol. 1997;145:33-41.
81. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ. 2002;325(7370):932-933.
82. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940-946.
83. Whalley LJ, Fox HC, Wahle KW, Starr JM, Deary IJ. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr. 2004;80:1650-1657.
84. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr. 2003;77:803-808.
85. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98.
86. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
87. Uauy R, Valenzuela A. Marine oils: the health benefits of n-3 fatty acids. Nutrition. 2000;16:680-684.
88. Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem. 2003;278:43807-43817.
89. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A. 2004;101:8491-8496.
90. Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22: 6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem. 2000;275:35215-35223.
91. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004;43:633-645.